Insider · CIK 0001283972
Klaus R Dr Veitinger
Files at SCPH (scPharmaceuticals Inc.). First filing -, latest -.
Klaus R Dr Veitinger files SEC Form 4 as director at SCPH (scPharmaceuticals Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Klaus R Dr Veitinger has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -30,000 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -19,750 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,300 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -6,124 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Jun 3, 2025 | SCPH scPharmaceuticals Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 5, 2025 |
Questions about Klaus R Dr Veitinger
Answered from the filings on this page, as of the latest one.
Is Klaus R Dr Veitinger buying or selling?
Klaus R Dr Veitinger has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Klaus R Dr Veitinger's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Klaus R Dr Veitinger has 0.
Where does Klaus R Dr Veitinger file Form 4?
Klaus R Dr Veitinger has filed Form 4 at SCPH (scPharmaceuticals Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.